These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 29456183)
41. Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Rampoldi A; Singh M; Wu Q; Duan M; Jha R; Maxwell JT; Bradner JM; Zhang X; Saraf A; Miller GW; Gibson G; Brown LA; Xu C Toxicol Sci; 2019 May; 169(1):280-292. PubMed ID: 31059573 [TBL] [Abstract][Full Text] [Related]
42. Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering. Hoes MF; Bomer N; van der Meer P Stem Cells Transl Med; 2019 Jan; 8(1):66-74. PubMed ID: 30302938 [TBL] [Abstract][Full Text] [Related]
43. Role of the renin-angiotensin system in cardiac hypertrophy. Yamazaki T; Komuro I; Yazaki Y Am J Cardiol; 1999 Jun; 83(12A):53H-57H. PubMed ID: 10750588 [TBL] [Abstract][Full Text] [Related]
45. Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes. Ovchinnikova E; Hoes M; Ustyantsev K; Bomer N; de Jong TV; van der Mei H; Berezikov E; van der Meer P Stem Cell Reports; 2018 Mar; 10(3):794-807. PubMed ID: 29456183 [TBL] [Abstract][Full Text] [Related]
46. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation. Zhang W; Kong CW; Tong MH; Chooi WH; Huang N; Li RA; Chan BP Acta Biomater; 2017 Feb; 49():204-217. PubMed ID: 27890729 [TBL] [Abstract][Full Text] [Related]
47. Nitric Oxide-cGMP-PKG Pathway Acts on Orai1 to Inhibit the Hypertrophy of Human Embryonic Stem Cell-Derived Cardiomyocytes. Wang Y; Li ZC; Zhang P; Poon E; Kong CW; Boheler KR; Huang Y; Li RA; Yao X Stem Cells; 2015 Oct; 33(10):2973-84. PubMed ID: 26269433 [TBL] [Abstract][Full Text] [Related]
48. Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy? Földes G; Mioulane M; Wright JS; Liu AQ; Novak P; Merkely B; Gorelik J; Schneider MD; Ali NN; Harding SE J Mol Cell Cardiol; 2011 Feb; 50(2):367-76. PubMed ID: 21047517 [TBL] [Abstract][Full Text] [Related]
49. Functional expression and pharmaceutical efficacy of cardiac-specific ion channels in human embryonic stem cell-derived cardiomyocytes. Kim HS; Yoon JW; Li H; Jeong GO; Park JJ; Shin SE; Jang IH; Kim JH; Park WS Sci Rep; 2017 Oct; 7(1):13821. PubMed ID: 29062050 [TBL] [Abstract][Full Text] [Related]
50. Uniaxial cyclic stretch stimulates TRPV4 to induce realignment of human embryonic stem cell-derived cardiomyocytes. Qi Y; Li Z; Kong CW; Tang NL; Huang Y; Li RA; Yao X J Mol Cell Cardiol; 2015 Oct; 87():65-73. PubMed ID: 26259779 [TBL] [Abstract][Full Text] [Related]
51. Accumulation of 5-oxoproline in myocardial dysfunction and the protective effects of OPLAH. van der Pol A; Gil A; Silljé HHW; Tromp J; Ovchinnikova ES; Vreeswijk-Baudoin I; Hoes M; Domian IJ; van de Sluis B; van Deursen JM; Voors AA; van Veldhuisen DJ; van Gilst WH; Berezikov E; van der Harst P; de Boer RA; Bischoff R; van der Meer P Sci Transl Med; 2017 Nov; 9(415):. PubMed ID: 29118264 [TBL] [Abstract][Full Text] [Related]
52. Human Pluripotent Stem Cell-Derived Cardiac Tissue-like Constructs for Repairing the Infarcted Myocardium. Li J; Minami I; Shiozaki M; Yu L; Yajima S; Miyagawa S; Shiba Y; Morone N; Fukushima S; Yoshioka M; Li S; Qiao J; Li X; Wang L; Kotera H; Nakatsuji N; Sawa Y; Chen Y; Liu L Stem Cell Reports; 2017 Nov; 9(5):1546-1559. PubMed ID: 29107590 [TBL] [Abstract][Full Text] [Related]
53. Is Load-Induced Ventricular Hypertrophy Ever Compensatory? Schiattarella GG; Hill TM; Hill JA Circulation; 2017 Oct; 136(14):1273-1275. PubMed ID: 28972060 [No Abstract] [Full Text] [Related]